Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review
Introduction Psoriasis is an immune-mediated disease affecting 125 million people worldwide and is characterized by both skin inflammation and systemic comorbidities. Up to one-third of psoriasis patients develop psoriatic arthritis, and patients with …